Plasma Phenylacetylglutamine and Cognitive Impairment After Ischemic Stroke
High plasma phenylacetylglutamine levels were associated with increased odds of PSCI at 3 months, suggesting that plasma phenylacetylglutamine might be a potential predictive biomarker for PSCI among patients with ischemic stroke.
Authors
- Tian Xu (ORCID: https://orcid.org/0000-0001-9278-1622)
- Xiaoxiao Wang (ORCID: https://orcid.org/0009-0002-3142-6007)
- Zhengbao Zhu (ORCID: https://orcid.org/0000-0001-5500-0014)
- Xiaoqing Bu (ORCID: https://orcid.org/0009-0007-4581-0444)
- Xinyue Chang (ORCID: https://orcid.org/0000-0001-7027-3889)
- Mengyao Shi (ORCID: https://orcid.org/0000-0002-5883-0416)
- Hao Yang Peng (ORCID: https://orcid.org/0000-0001-6277-662X)
- Yi Liu (ORCID: https://orcid.org/0000-0002-2051-440X)
- Yonghong Zhang (ORCID: https://orcid.org/0000-0001-6188-3490)
- Yang Liu (ORCID: https://orcid.org/0009-0002-3303-5018)
- Tan Xu (ORCID: https://orcid.org/0000-0003-3798-1247)
- Aili Wang (ORCID: https://orcid.org/0000-0002-8124-9697)
- W. Yang (ORCID: https://orcid.org/0009-0003-7391-8381)
- Jiawen Fei
- Yu He (ORCID: https://orcid.org/0009-0001-0179-6149)
Institutions
- Tulane University (US)
- Soochow University (TW)
- Nantong University (CN)
- Soochow University (CN)
- Affiliated Hospital of Nantong University (CN)
- First Affiliated Hospital of Soochow University (CN)
- Chongqing Public Health Medical Center (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1161/jaha.125.042955
- Primary Topic
- Metabolism and Genetic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00